SCHEMBL8066970

SCHEMBL8066970

O=C(O)COc1cccc(-c2cccc(-c3nc(-c4ccccc4)c(-c4ccccc4)o3)c2)c1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 7/20 0.79
KDM4E B2RXH2 1/20 0.74
MEN1 O00255 1/20 0.74
ALDH1A1 P00352 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP2D6 P10635 1/20 0.74
HPGD P15428 1/20 0.74
KMT2A Q03164 1/20 0.74
HSD17B10 Q99714 1/20 0.74
PTGIR P43119 8/20 0.58
PTGER4 P35408 1/20 0.52
PTGER3 P43115 1/20 0.52
FABP5 Q01469 3/20 0.49
FABP3 P05413 2/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
PPARD Q03181 1/20 0.48
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9428515 0.93 MEN1 (0.82) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL30398835 0.88 FABP4 (1.00) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL9428317 0.88 FABP4 (1.00) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL8072043 0.87 FABP4 (0.61) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL9428853 0.86 KDM4E (0.76) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL674739 0.85 KDM4E (1.00) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL29640642 0.85 KDM4E (1.00) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL9428337 0.84 FABP4 (0.73) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL14528476 0.83 FABP4 (0.77) FABP4KDM4EMEN1ALDH1A1CYP1A2
SCHEMBL14084597 0.81 FABP4 (0.66) FABP4KDM4EMEN1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0736018-B1 4,5-DIARYLOXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2000-07-05 EP disclosed
US-6025375-A INHIBITORY ACTIVITY ON PLATELET AGGREGATION, VASODILATING ACTIVITY, ANTIHYPERTENSIVE ACTIVITY OR THE LIKE AND ARE PROSTAGLANDIN I.SUB.2 AGONISTS, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-02-15 US disclosed
WO-1995017393-A1 4,5-DIARYLOXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-06-29 WO disclosed